Cargando…

Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease

BACKGROUND/AIMS: Advanced fibrosis (F≥3) indicates poor outcomes in nonalcoholic fatty liver disease (NAFLD). Here, we examined the diagnostic performance of the fibrosis-4 index (FIB-4) and NAFLD fibrosis score (NFS) for detecting (or excluding) advanced fibrosis in patients with biopsy-proven NAFL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaya, Eda, Bakir, Alev, Kani, Haluk Tarik, Demirtas, Coskun Ozer, Keklikkiran, Caglayan, Yilmaz, Yusuf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366150/ https://www.ncbi.nlm.nih.gov/pubmed/31530739 http://dx.doi.org/10.5009/gnl19173

Ejemplares similares

Causes of erectile dysfunction in non-alcoholic fatty liver disease
por: Tarik Kani, Haluk, et al.
Publicado: (2021)

The utility of noninvasive scores in non-alcoholic fatty liver disease patients with normal and elevated serum transaminases
por: Kaya, Eda, et al.
Publicado: (2020)

High incidence of hepatitis B core antibody positivity in metabolic-associated fatty liver disease-related cirrhosis
por: Ergenc, Ilkay, et al.
Publicado: (2021)

The clinical and histological characteristics of patients with biopsy-proven non-alcoholic fatty liver disease in the absence of insulin resistance
por: Demirtas, Coskun Ozer, et al.
Publicado: (2020)

Metabolic-associated Fatty Liver Disease: Time to integrate ground-breaking new terminology to our clinical practice?
por: Demirtas, Coskun Ozer, et al.
Publicado: (2020)

The risk of development of primary biliary cholangitis among incidental antimitochondrial M2 antibody-positive patients
por: Ergenc, Ilkay, et al.
Publicado: (2023)

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
por: Kim, Young Seok, et al.
Publicado: (2013)

Evaluation of the effectiveness of drug-eluting transarterial chemoebolization in hepatocellular carcinoma
por: Alan, Aydan Mutis, et al.
Publicado: (2023)

The comparison of resting metabolic rate between biopsy-proven non-alcoholic steatohepatitis and non-alcoholic fatty liver patients
por: Kenger, Emre Batuhan, et al.
Publicado: (2020)

Chronotype preference, sleep quality, and night-eating behaviors in patients with metabolic dysfunction-associated steatotic liver disease: Assessing the relationship with disease severity and fibrosis
por: Kani, Ayse Sakalli, et al.
Publicado: (2023)

Serum Progranulin as an Independent Marker of Liver Fibrosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease
por: Yilmaz, Yusuf, et al.
Publicado: (2011)

Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease
por: Kaya, Eda, et al.
Publicado: (2022)

Mitochondrial DNA common deletion is not associated with thyroid, breast and colorectal tumors in Turkish patients
por: Aral, Cenk, et al.
Publicado: (2010)

Prevalence of biopsy-proven nonalcoholic fatty liver among patients with gallstone disease
por: Alsaif, Faisal A., et al.
Publicado: (2020)

Patients with computed tomography-proven acute diverticulitis require follow-up to exclude colorectal cancer
por: Zaman, Shafquat, et al.
Publicado: (2017)

Anogenital Distance in Turkish Newborns
por: Oğuz Kutlu, Alev
Publicado: (2012)

Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease
por: Arai, Taeang, et al.
Publicado: (2019)

Serum Metabolites Are Associated With HFpEF in Biopsy‐Proven Nonalcoholic Fatty Liver Disease
por: Wegermann, Kara, et al.
Publicado: (2023)

The prevalence of metabolic-associated fatty liver disease in the Turkish population: A multicenter study
por: Yilmaz, Yusuf, et al.
Publicado: (2021)

Normative Data for Penile Length in Turkish Newborns
por: Kutlu, Alev Oğuz
Publicado: (2010)

Confocal Microscopy in Biopsy Proven Argyrosis
por: Palamar, Melis, et al.
Publicado: (2013)

Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
por: Demirtas, Coskun Ozer, et al.
Publicado: (2021)

Surveillance of hepatocellular carcinoma in cirrhotic patients: Current knowledge and future directions
por: Demirtas, Coskun Ozer, et al.
Publicado: (2020)

Is There a More Practical Way for Screening Minimal Hepatic Encephalopathy?
por: Tosun, Şerife Değirmencioğlu, et al.
Publicado: (2023)

Prevalence of metabolic dysfunction-associated fatty liver disease in kidney transplant recipients: A cross-sectional study using FibroScan
por: Yesil, Ezgi Ersoy, et al.
Publicado: (2023)

The association of fat preference with eating behavior and sex: Turkish version of the Fat Preference Questionnaire(©)
por: Okan Bakır, Binnur, et al.
Publicado: (2021)

The Turkish state’s responses to existential COVID-19 crisis
por: Bakir, Caner
Publicado: (2020)

Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease
por: Arai, Taeang, et al.
Publicado: (2021)

Hyperferritinemia Correlates to Metabolic Dysregulation and Steatosis in Chinese Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients
por: Wang, Qingling, et al.
Publicado: (2022)

Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease
por: Lee, Dae Ho
Publicado: (2020)

The role of noninvasive tests and liver biopsy in the diagnosis of nonalcoholic fatty liver disease
por: Isabela Andronescu, Craita, et al.
Publicado: (2018)

Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver
por: Kaya, Eda, et al.
Publicado: (2022)

Insidious danger for young adults: Metabolic (dysfunction)-associated fatty liver disease
por: Kaya, Eda, et al.
Publicado: (2022)

The role of FibroScan in the era of metabolic (dysfunction)-associated fatty liver disease
por: Yilmaz, Yusuf, et al.
Publicado: (2023)

Excluded
por: Asai, David
Publicado: (2020)

Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease
por: Yang, Hye Ran
Publicado: (2013)

Noninvasive Markers for the Diagnosis of Nonalcoholic Fatty Liver Disease
por: Kim, Sang Yong
Publicado: (2013)

Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease
por: Jayasekera, Dulshan, et al.
Publicado: (2023)

Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease
por: Gîlcă-Blanariu, Georgiana-Emmanuela, et al.
Publicado: (2023)

Whole Genome Sequence of a Turkish Individual
por: Dogan, Haluk, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jnrv7efi182asmasr37n0jv5l7